Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports

Figure 8 Dynamic contrast-enhanced computed tomography findings at 80 wk after lenvatinib administration in case 2. A and B: Arterial-phase computed tomography image at 80 wk after the start of lenvatinib administration showing further decrease of the size of the hepatocellular carcinomas and the tumor thrombus in the main portal vein (arrows) (A) and further decrease of the size of the tumor thrombus in the inferior vena cava (arrows) (B).